BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 34963449)

  • 1. Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.
    Zhang ZA; Xin X; Liu C; Liu YH; Duan HX; Qi LL; Zhang YY; Zhao HM; Chen LQ; Jin MJ; Gao ZG; Huang W
    J Nanobiotechnology; 2021 Dec; 19(1):453. PubMed ID: 34963449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
    Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H
    Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
    Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
    Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles.
    Lv L; Jiang Y; Liu X; Wang B; Lv W; Zhao Y; Shi H; Hu Q; Xin H; Xu Q; Gu Z
    Mol Pharm; 2016 Oct; 13(10):3506-3517. PubMed ID: 27636161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery.
    Guan J; Zhang Z; Hu X; Yang Y; Chai Z; Liu X; Liu J; Gao B; Lu W; Qian J; Zhan C
    Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28841776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide.
    Ran D; Zhou J; Chai Z; Li J; Xie C; Mao J; Lu L; Zhang Y; Wu S; Zhan C; Lu W
    Theranostics; 2020; 10(9):4073-4087. PubMed ID: 32226540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.
    Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W
    Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.
    Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y
    J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting.
    Tang B; Zaro JL; Shen Y; Chen Q; Yu Y; Sun P; Wang Y; Shen WC; Tu J; Sun C
    J Control Release; 2018 Jun; 279():147-156. PubMed ID: 29653223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
    Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
    Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
    Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
    Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
    Zhu J; Zhang Y; Chen X; Zhang Y; Zhang K; Zheng H; Wei Y; Zheng H; Zhu J; Wu F; Piao JG; Zhu Z; Li F
    Biochem Biophys Res Commun; 2021 Jan; 534():902-907. PubMed ID: 33162028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles.
    Zheng J; Wan Y; Elhissi A; Zhang Z; Sun X
    Pharm Res; 2014 Aug; 31(8):2220-33. PubMed ID: 24595496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
    Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
    Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.